Clinical trials: sponsored by Peking University
Bone Aging, Osteoporosis Diagnosis
Automated Bone Age Estimation From Noncontrast Abdominal CT Using Deep Learning
This study is a retrospective analysis that uses abdominal CT scans, which were originally taken for other medical reasons, to estimate bone age.
- Trial name
- NCT07162168
- Where
- China
- Volunteers
- 3,000 people, healthy volunteers welcome
- Sponsor
- Peking University People's Hospital
Wound Heal, Wound Healing Delayed
An Exploratory Research on the Efficacy and Safety of Antibacterial Absorbable Dressing in Chronic Non-healing Wounds
Antimicrobial absorbable wound dressing is a novel polyester-based degradable dressing. Previous preclinical studies have demonstrated promising efficacy, with a 3-week wound area reduction rate of 63.53% in large animal models…
- Trial name
- NCT07261501
- Testing
- antimicrobial absorbable wound dressing
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Peking University Third Hospital
Wound - in Medical Care
Wound Assessment Accuracy and Treatment Efficiency
Wound assessment is critical for developing effective treatment strategies, yet there is a scarcity of research on the assessment accuracy of clinical practitioners.
- Trial name
- NCT07261488
- Where
- China
- Volunteers
- 553 people
- Sponsor
- Peking University Third Hospital
Diabetic Wound, Chronic Wound Care
Mailuo Shutong Pills for Diabetic Wound Healing: A Multicenter Randomized Trial
Mailuo Shutong Pills are a Chinese patent medicine approved for market release by the China Food and Drug Administration (CFDA) in 2009.
- Trial name
- NCT07258381
- Testing
- Mailuo Shutong Pills, Blank control
- Volunteers
- 56 people
- Sponsor
- Peking University Third Hospital
Mantle Cell Lymphoma (MCL), POZ
Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma
This multicenter trial evaluates the efficacy and safety of pomalidomide combined with orelabrutinib and zuberitamab (POZ) in patients with mantle cell lymphoma (MCL).
- Trial name
- NCT07257510
- Testing
- Pomalidomide, Orelabrutinib, Zuberitamab
- Where
- China
- Volunteers
- 34 people
- Sponsor
- Peking University Third Hospital
Hepatoid Adenocarcinoma of Stomach
Perioperative Therapy for HER2-negative Hepatoid Adenocarcinoma of Stomach
The goal of this clinical trial is to learn if treatment modality including albumin-bound paclitaxel, oxaliplatin, tegafur,gimeracil and oteracil porassium capsules (SOX) and sintilimab works to treat locally advanced…
- Trial name
- HASCHANGE02 (NCT07178340)
- Testing
- Perioperative treatment with albumin-bound paclitaxel, oxaliplatin, tegafur,gimeracil and oteracil porassium capsules and sintilimab.
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Peking University Cancer Hospital & Institute
Aplastic Anemia, Pregnancy
A Prediction Model in Pregnant Women With Aplastic Anemia
Aplastic anemia (AA) is a rare haematologic disorder characterized by bone marrow failure and pancytopenia. Its occurrence during pregnancy is exceedingly rare but poses significant risks, including maternal hemorrhage…
- Conditions
- Aplastic Anemia, Pregnancy, Prediction Model
- Trial name
- NCT07101770
- Testing
- A combined retrospective and prospective observational follow-up
- Where
- China
- Volunteers
- 300 people
- Sponsor
- Peking University People's Hospital
Breast Cancer, Brain Metastases From Breast Cancer
Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study
The goal of this real-world study (RWS) is to evaluate the effectiveness of Trop-2 ADC (sacituzumab govitecan) in treating breast cancer patients with brain metastases, and to understand the safety profile of this drug in real…
- Conditions
- Breast Cancer, Brain Metastases From Breast Cancer, Trop2
- Trial name
- NCT07251868
- Testing
- Sacituzumab Govitecan (SG)
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Peking University Cancer Hospital & Institute
Lung Cancer (Diagnosis), Pain Management
Impact of Perioperative Body Temperature on Postoperative Complications and Pain in Video-assisted Thoracoscopic Surgery Patients Utilizing Continuous Temperature Monitoring
A report from the National Cancer Center (published in JNCC) shows that lung cancer has the highest rates of both new cases and deaths in China.
- Conditions
- Lung Cancer (Diagnosis), Pain Management, Postoperative Complications, Body Temperature Measurement
- Trial name
- NCT07251439
- Testing
- Continuous body temperature monitoring
- Volunteers
- 144 people
- Sponsor
- Peking University People's Hospital
Locally Advanced Rectal Cancer
Neoadjuvant Long-course Chemoradiotherapy Followed by Immunotherapy for Locally Advanced Mid-low Rectal Cancer
The purpose of this study was to evaluate the effect of capecitabine-based long-term radiotherapy followed by 3 cycles Sintilimab (PD-1 inhibitor) in patients with locally advanced rectal cancer.
- Trial name
- NLCCRIT-LARC (NCT06493240)
- Testing
- radiation, PD-1 Monoclonal Antibody, TME surgery
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Peking University People's Hospital
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Effect of Metformin on Patients With Polycystic Ovary Syndrome
The purpose of the study is to understand the effect of Metformin on patients with PCOS.
- Trial name
- NCT05802212
- Testing
- Metformin intervention for 12 weeks
- Where
- China
- Volunteers
- 77 people
- Sponsor
- Peking University Third Hospital
Polycystic Ovary Syndrome
Effect of NMN (Nicotinamide Mononucleotide) on Polycystic Ovary Syndrome
The purpose of the study is to understand the effect of Nicotinamide mononucleotide (NMN) on patients with polycystic ovary syndrome.
- Trial name
- NMN (NCT05305677)
- Testing
- NMN intervention
- Where
- China
- Volunteers
- 88 people
- Sponsor
- Peking University Third Hospital
Health Problems in Pregnancy, Pregnancy Outcomes
Peking University Birth Cohort in Weifang (PKUBC-WF)
The PKUBC-WF is a prospective cohort study carried out in Weifang city of Shandong, China. The primary aim of this study is to investigate the short-term and long-term effects of pre-pregnant and prenatal exposure on maternal and…
- Conditions
- Health Problems in Pregnancy, Pregnancy Outcomes, Gestational Diabetes, Gestational Hypertension
- Trial name
- NCT06234332
- Testing
- No Interventions
- Where
- China
- Volunteers
- 2,800 people, healthy volunteers welcome
- Sponsor
- Peking University
Rheumatoid Arthritis (RA)
Rehabilitation Exercise Intervention for Rheumatoid Arthritis Patients Using Artificial Intelligence-Based Exercise Prescription System
This is a single-center, randomized, parallel-controlled trial evaluating the efficacy and safety of an artificial intelligence-based exercise prescription system for rehabilitation in rheumatoid arthritis (RA) patients.
- Trial name
- NCT07246811
- Testing
- AI Exercise Prescription, education and basic joint mobility exercises, paper-based exercise prescription
- Where
- China
- Volunteers
- 147 people
- Sponsor
- Peking University Third Hospital
II-IIIB (T3N2) Resectable Non-small Cell Lung Cancer, Perioperative
Ivonescimab Monotherapy or in Combination With Chemotherapy as Neoadjuvant/Adjuvant Therapy for Resectable Non-small Cell Lung Cancer
This study is a prospective, II Phase clinical trial designed to evaluate the efficacy and safety of ivonescimab as monotherapy or in combination with platinum-based chemotherapy in the perioperative treatment of resectable…
- Trial name
- NCT07241819
- Testing
- Ivonescimab/surgery, Ivonescimab/chemotherapy/surgery
- Volunteers
- 66 people
- Sponsor
- Peking University Cancer Hospital & Institute
Chronic Wound, Hard to Heal Wounds
A RCT of Moist Ag Dressing in Chronic Wound
This study aims to explore the differences in efficacy and cost-effectiveness between self-adhesive soft polysilicone silver ion foam dressings and traditional silver dressings in local infected wounds through a prospective…
- Conditions
- Chronic Wound, Hard to Heal Wounds, Dressing, Wound he'a'Ling
- Trial name
- NCT07235254
- Testing
- Ag foam dressing named MepilexAg, Dry Ag dressing
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Peking University Third Hospital
Diabetic Wound
Macrophage Stimulating Factor in the Treatment of Diabetic Wounds
With the aging of the population, the incidence of diseases such as diabetes, chronic atherosclerotic occlusion, cerebrovascular disease, and cancer is increasing year by year, and has led to an increasing incidence of chronic…
- Trial name
- NCT06608303
- Testing
- Topical Human Granulocyte Macrophage Stimulating Factor Gel
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Peking University Third Hospital
Mild Cognitive Disorder
Study on the Effect of Online Cognitive Training Doses on Cognitive Function in Individuals With Mild Cognitive Decline
The primary questions that this clinical trial aims to answer are: To compare the differences in the efficacy of different doses of Computerized Cognitive Training (CCT) in improving cognitive function among patients with Mild…
- Trial name
- NCT07213362
- Testing
- Computerized Cognitive Training
- Volunteers
- 234 people
- Sponsor
- Peking University
Esophageal Cancer (EsC)
A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma
This study is a prospective, observational clinical study. In this study, 30 patients with resectable locally advanced esophageal squamous carcinoma will be prospectively enrolled and treated with adebrelimab (SHR-1316) combined…
- Trial name
- NCT06869213
- Testing
- Adebrelimab (SHR-1316) + Nab-paclitaxel + Cisplatin
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Peking University Cancer Hospital & Institute
Esophageal Cancer
A Multicenter Phase II Clinical Study of Neoadjuvant Use of Camrelizumab in Combination With Chemotherapy for Organ Preservation in Esophageal Cancer
This is a multicenter phase II clinical study to explore the efficacy, safety, and organ preservation feasibility of camrelizumab in combination with chemotherapy for resectable esophageal squamous carcinoma in patients with…
- Trial name
- NCT06869226
- Testing
- Camrelizumab + Nab-paclitaxel + Cisplatin
- Where
- China
- Volunteers
- 283 people
- Sponsor
- Peking University Cancer Hospital & Institute
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.